Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Market Closed - Euronext Paris 03:55:00 14/11/26 am AEDT			5-day change	1st Jan Change
0.7210 ^EUR	-1.23%		-3.61%	-24.90%

10/11	Transgene confirms financial visibility through 2028
10/11	Weekly earnings agenda: SoftBank, CoreWeave, Nebius… AI looking for reassurance

Evolution of the Average Target: Transgene

Evolution of the Average Target - Transgene

Evolution of the Target Price: Transgene

Evolution of the Target Price - Transgene

Changes in Analyst Recommendations: Transgene

048861f6309f4b3a0f044.dBc9QxTlxvL6h2PYilmMbxr7Z8huRCWGTfTXJvKxqwg.JTpQAiy3qYjCxgeP3RvaNiOBEa82JXbrfryYE5zu6UkVXEUQVpW1ipvvJg~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

25/06	Oddo BHF Stays Positive on Transgene
07/04	Transgene stands out following licensing agreement with NEC Bio
28/11	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/10/25	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
19/09/25	Transgene: analysts reiterate their recommendations after results
17/09/25	The day the Fed resumed its rate cuts
07/11/24	Transgene: Invest Securities remains Buy
15/10/24	Transgene: Invest Securities confirms its Buy recommendation
26/09/24	Transgene: Invest Securities confirms its opinion
06/06/23	Transgene: Invest Securities confirms its Buy rating
05/06/23	Transgene: Invest Securities reiterates its recommendation
22/03/23	Transgene: Invest Securities reduces its target
10/01/23	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+52.57%
	WUXI APPTEC CO., LTD.					+38.3%
	ARGENX SE					+15.44%
	LONZA GROUP AG					+7.53%
	BEONE MEDICINES AG					+12.65%
	IQVIA HOLDINGS INC.					+17.64%
	REVOLUTION MEDICINES, INC.					+59.52%
	CELLTRION, INC.					+30.16%
	GENMAB A/S					+17.66%
	INSMED INCORPORATED					+60.27%
	Average					+31.17%
	Weighted average by Cap.					+26.49%

See all sector performances

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7210EUR

Average target price

1.100EUR

Spread / Average Target

+52.57%

High Price Target

1.100EUR

Spread / Highest target

+52.57%

Low Price Target

1.100EUR

Spread / Lowest Target

+52.57%

Analyst Consensus Detail

Analyst consensus - Transgene

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Transgene

Stock Market
Stocks
TNG Stock
Consensus Transgene